Navigation Links
Escalon(R) Medical Corp. Completes $1.1 Million Private Equity Financing
Date:11/21/2008

, improve upon the operations of the Company business units, including the ability to make acquisitions and the integration of any acquisitions it may undertake, if any, of which there can be no assurance,
  • implement cost reductions,
  • generate cash,
  • identify, finance and enter into business relationships and acquisitions
  • new product development, commercialization, manufacturing and market acceptance of new products,.
  • Other factors include uncertainties and risks related to:

    • marketing acceptance of existing products in new markets,
    • research and development activities, including failure to demonstrate clinical efficacy,
    • delays by regulatory authorities, scientific and technical advances by the Company or third parties,
    • introduction of competitive products,
    • ability to reduce staffing and other costs and retain benefit of prior reductions
    • third party reimbursement and physician training, and
    • general economic conditions.

    Further information about these and other relevant risks and uncertainties may be found in the Company's reports on Form 10-K for year ended June 30, 2008 and Form 10-Q for the quarter ended September 30, 2008, and its other filings with the Securities and Exchange Commission, all of which are available from the Securities and Exchange Commission as well as other sources.


    '/>"/>
    SOURCE Escalon Medical Corp.
    Copyright©2008 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine news :

    1. Escalon(R) Reports First Quarter Fiscal 2009 Results
    2. Escalon(R) Receives FDA 510(k) Clearance to Market the LIASYS(TM) Clinical Chemistry and Immunoturbidimetric Analyzer
    3. Escalon(R) Enhances Position Within IVD Reagent Market with Strategic Acquisition of JAS Diagnostics
    4. Escalon(R) Announces China Registration for Sonomed PacScan(R) and E/Z-Scan(R) Series of A-scan, Pachymeter and B-Scan Systems
    5. Escalon(R) Announces Executive Promotions
    6. Escalon(R) Announces FDA 510(K) Clearance for D3 Hematology System
    7. Escalon(R) Reports First Quarter Fiscal 2008 Results
    8. Escalon(R) Reports Financial Results for 2007 Fiscal Year
    9. OmniVision Unveils 1.8 mm, Low Power Medical Sensor With Best-in-Class Low Light Performance
    10. ReachMD Announces New Strategic Partnership with American Medical Directors Association
    11. Photos: Nevadas Saint Marys Regional Medical Center Raises $1.3 Million During Centennial Soiree
    Post Your Comments:
    *Name:
    *Comment:
    *Email: